Nihon Kohden Corporation

2026/08/21 Updated
Market Cap: $1.5B (¥243.7B)
Stock Price: $9.58 (¥1,524)
Exchange Rate: 1 USD = ¥158.98

Stock Price Chart

2026/08/21 Updated
16.61
PER (Price Earnings Ratio)
vs Industry Avg: +7.1
1.38
PBR (Price to Book Ratio)
vs Industry Avg: +0.1
2.17%
Dividend Yield
vs Industry Avg: -0.78%

Price Trend

2026/08/21 Updated
Short-term
5-Day MA
+2.65%
Near-term
25-Day MA
-0.83%
Mid-term
75-Day MA
+3.54%
Long-term
200-Day MA
-2.45%

Price & Trading Details

2026/08/21 Updated

PRICE

Previous Close ¥1,484
Open ¥1,508
High ¥1,536
Low ¥1,500
Close ¥1,524

TRADING

Volume 557,100
Average Volume 718,177
Turnover ¥8億
Min. Purchase ¥152,350

Analyst Recommendations 8 analysts

Updated 2026/08/01
Strong Buy
2
2
Buy
2
2
Hold
4
4
Sell
0
Strong Sell
0
Target Price (Mean)
¥1,854
Buy
¥2,200
High
¥1,850
Median
¥1,500
Low
+10% vs Current Price
This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Earnings Calendar

Updated 2026/08/01
AUG
06
2026
Next Earnings Release
Q3 FY2026
EPS Estimate: ¥2.45

Recent Earnings

Date EPS Est. EPS Actual Surprise
2026/05/14 ¥33.97 ¥49.94 +47.0%
2026/02/04 ¥12.99 ¥11.57 -10.9%
2025/11/10 ¥23.30 ¥26.90 +15.4%
2025/08/05 ¥2.45 ¥0.84 -65.8%

Shareholder Composition

Updated 2026/08/01
0.8%
Insider Holdings
59.0%
Institutional
40.2%
Public Float
104
Institutional Holders
Insider Holdings 0.8%
Institutional 59.0%
Public Float 40.2%

Major Holders

Updated 2026/08/01
Institution Ownership Shares Change
First Eagle Funds-First Eagle Overseas Fund
4.04%
6.8M 0.00%
VANGUARD TRUSTEES' EQUITY FUND-Vanguard International Value Fund
1.83%
3.1M -1.94%
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
1.37%
2.3M 0.00%
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
0.91%
1.5M +0.11%
iShares Trust-iShares Core MSCI EAFE ETF
0.71%
1.2M 0.00%
-First Eagle Overseas Equity ETF
0.38%
644.3K +52.61%

Dividend History

Updated 2026/08/16
-%
Dividend Yield
¥16
Annual Dividend
-50.0%
YoY Growth
17.9%
Payout Ratio
Year Dividend Change
2026 ¥16 -50.0%
2025 ¥32 +4.9%
2024 ¥31 -14.1%
2023 ¥36 +4.4%
2022 ¥34 -

Financial Performance

2026/08/16 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

2022 2023 2024 2025
Income Statement
Revenue ¥205,129M ¥206,603M ¥221,986M ¥225,424M
Gross Profit ¥109,085M ¥105,926M ¥111,346M ¥117,157M
Operating Income ¥30,992M ¥21,121M ¥19,591M ¥20,713M
Pretax Income ¥34,274M ¥24,726M ¥29,393M ¥21,714M
Net Income ¥23,435M ¥17,110M ¥17,026M ¥14,098M
EPS ¥138.25 ¥101.64 ¥101.22 -
Operating Margin 15.11% 10.22% 8.83% 9.19%
Balance Sheet
Total Assets ¥210,201M ¥216,728M ¥233,233M ¥258,276M
Total Equity ¥156,378M ¥167,602M ¥181,080M ¥179,550M
Total Liabilities ¥53,823M ¥49,126M ¥52,153M ¥78,726M
Cash ¥28,925M ¥33,459M ¥36,132M ¥28,428M
Interest-bearing Debt ¥359M ¥441M ¥654M ¥26,076M
Equity Ratio 74.39% 77.33% 77.64% 69.52%
D/E Ratio 0.00 0.00 0.00 0.15
Cash Flow
Operating CF ¥25,699M -¥2,513M ¥15,607M ¥15,286M
Investing CF -¥4,303M -¥7,647M -¥5,208M -¥25,138M
Financing CF -¥7,300M -¥7,485M -¥6,968M ¥2,550M
Free CF ¥22,765M -¥10,769M ¥10,821M ¥6,577M
Efficiency
ROE 14.99% 10.21% 9.40% 7.85%
ROA 11.15% 7.89% 7.30% 5.46%

Latest IR Information

Company Information

English Name Nihon Kohden Corporation
Japanese Name 日本光電
Stock Code 6849.T (JPX)
Sector / Industry Healthcare / Medical Devices
Employees 6,116

About

Nihon Kohden Corporation engages in research and development, production, sales, and repair and maintenance of medical electronic equipment in Japan, North America, Latin America, Europe, Asia, and internationally. It offers physiological measuring equipment, such as electroencephalographs, evoked potential and electromyogram measuring systems, electrocardiographs, polygraphs for Cath lab, diagnostic information systems, recording paper, electrodes, and EP catheters. The company also provides patient monitors such as central monitors, bedside monitors, wireless monitors, remote access software and other equipment, clinical information systems, and electrodes and sensors. In addition, it offers Defibrillators, AEDs, ventilators, pacemakers, anesthesia machines, cochlear implants, automated chest compression devices, AED pads, batteries, and ablation catheters; hematology analyzers, clinical chemistry analyzers, ultrasound diagnostic equipment and others, consumables, including test reagents, and installation and maintenance services. Further, it is involved in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.

Data provided by Yahoo Finance